Wellbeing International Foundation: From Laboratory to Patient Care

The journey from scientific discovery to effective clinical application is often long and complex. Wellbeing International Foundation has successfully navigated this path, translating groundbreaking research into treatments that are changing lives around the world.

This journey began in 1993 when Dr. Stephen Ray discovered that stem cells’ therapeutic effects came primarily from their secretions rather than the cells themselves. This insight led to decades of laboratory research focused on extracellular vesicles (EVs)—tiny packets of biological material that carry proteins, lipids, and RNA essential for tissue repair.

The foundation’s commitment to rigorous science is evident in their research partnerships with prestigious institutions including Oxford Brookes University, University College London, and the University of Reading. These collaborations have resulted in numerous published studies validating the effectiveness of their cell-free approach and uncovering new applications for their therapy.

In 2010, after years of protocol development and refinement, Wellbeing began treating clients in Switzerland with the approval of Swiss medical authorities. This marked the transition from theoretical research to practical application, with treatments initially focused on neurodegenerative conditions and musculoskeletal injuries.

Today, Wellbeing International Foundation operates from its headquarters in Hamilton, Bermuda, providing cell-free therapy to patients worldwide. Their client-centred approach ensures that each treatment is tailored to the individual, with careful monitoring and follow-up to assess outcomes and make adjustments as needed.

The foundation maintains a strong focus on both clinical care and ongoing research. As Max Lewinsohn, the current Chairman, explains, “To maintain and enhance its reputation it will support and sponsor continued research in the use of extracellular vesicles to assist in the treatment of a wider range of medical conditions, in addition to refining and optimising the process.”

This dual commitment to science and patient care has positioned Wellbeing International Foundation at the forefront of regenerative medicine. Their success demonstrates the value of translational research—taking discoveries from the laboratory bench to the patient’s bedside—and the potential of innovative therapies to address conditions where traditional approaches fall short.